XML 19 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Bausch Health Companies Inc. Shareholders' (Deficit) Equity
Bausch Health Companies Inc. Shareholders' (Deficit) Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Non- controlling Interest
Beginning Balance (in shares) at Dec. 31, 2019         352,600,000          
Beginning Balance at Dec. 31, 2019 $ 1,136 $ (1) $ 1,063 $ (1) $ 10,172 $ 429 $ (7,452) $ (1) $ (2,086) $ 73
Increase (Decrease) in Shareholders' Equity                    
Common shares issued under share-based compensation plans (in shares)         2,400,000          
Common shares issued under share-based compensation plans 2   2   $ 47 (45)        
Share-based compensation 81   81     81        
Employee withholding taxes related to share-based awards (30)   (30)     (30)        
Noncontrolling interest distributions (6)                 (6)
Net income (loss) (407)   (407)       (407)      
Other comprehensive (loss) income (120)   (121)           (121) 1
Ending Balance (in shares) at Sep. 30, 2020         355,000,000.0          
Ending Balance at Sep. 30, 2020 655   587   $ 10,219 435 (7,860)   (2,207) 68
Beginning Balance (in shares) at Jun. 30, 2020         354,900,000          
Beginning Balance at Jun. 30, 2020 546   474   $ 10,217 411 (7,931)   (2,223) 72
Increase (Decrease) in Shareholders' Equity                    
Common shares issued under share-based compensation plans (in shares)         100,000          
Common shares issued under share-based compensation plans 0       $ 2 (2)        
Share-based compensation 27   27     27        
Employee withholding taxes related to share-based awards (1)   (1)     (1)        
Noncontrolling interest distributions (6)                 (6)
Net income (loss) 70   71       71     (1)
Other comprehensive (loss) income 19   16           16 3
Ending Balance (in shares) at Sep. 30, 2020         355,000,000.0          
Ending Balance at Sep. 30, 2020 $ 655   587   $ 10,219 435 (7,860)   (2,207) 68
Beginning Balance (in shares) at Dec. 31, 2020 355,422,347       355,400,000          
Beginning Balance at Dec. 31, 2020 $ 605   535   $ 10,227 454 (8,013)   (2,133) 70
Increase (Decrease) in Shareholders' Equity                    
Common shares issued under share-based compensation plans (in shares)         3,800,000          
Common shares issued under share-based compensation plans 21   21   $ 85 (64)        
Share-based compensation 95   95     95        
Employee withholding taxes related to share-based awards (48)   (48)     (48)        
Release of foreign currency translation losses upon disposal of assets held for sale 340   340           340  
Noncontrolling interest distributions (10)                 (10)
Net income (loss) (1,009)   (1,017)       (1,017)     8
Other comprehensive (loss) income $ (129)   (130)           (130) 1
Ending Balance (in shares) at Sep. 30, 2021 359,154,635       359,200,000          
Ending Balance at Sep. 30, 2021 $ (135)   (204)   $ 10,312 437 (9,030)   (1,923) 69
Beginning Balance (in shares) at Jun. 30, 2021         358,700,000          
Beginning Balance at Jun. 30, 2021 (611)   (687)   $ 10,300 413 (9,218)   (2,182) 76
Increase (Decrease) in Shareholders' Equity                    
Common shares issued under share-based compensation plans (in shares)         500,000          
Common shares issued under share-based compensation plans 6   6   $ 12 (6)        
Share-based compensation 33   33     33        
Employee withholding taxes related to share-based awards (3)   (3)     (3)        
Release of foreign currency translation losses upon disposal of assets held for sale 340   340           340  
Noncontrolling interest distributions (10)                 (10)
Net income (loss) 191   188       188     3
Other comprehensive (loss) income $ (81)   (81)           (81)  
Ending Balance (in shares) at Sep. 30, 2021 359,154,635       359,200,000          
Ending Balance at Sep. 30, 2021 $ (135)   $ (204)   $ 10,312 $ 437 $ (9,030)   $ (1,923) $ 69